Camber: Camber Pharmaceuticals Shows Continued Growth in the Generic Marketplace

As an organization, the goal of Camber Pharmaceuticals Inc. is to be its customer’s first choice for multisource generic prescription products. Camber strives to be the most reliable and cost effective generic pharmaceutical supplier across a broad range of therapeutic classes. Camber manufactures and markets a superior value to the generic marketplace. From quality API’s, intermediates, finished goods to exceptional customer service and logistics, the Camber story has become a standard of excellence in the pharmaceutical industry.

With new product releases that include Indomethacin ER, Indomethacin, Gabapentin Tablets and Capsules, Levocetirizine, Levetiracetam, Levetiracetam Oral Solution, Escitalopram Oral Solution and Escitalopram Tablets, Camber will remain one of the fastest growing generic companies in the USA for years to come. Camber has been recognized as one of the Top 20 overall pharmaceutical companies in Dispensed Prescriptions. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.

Working with highly respected nonprofits such as AmeriCares, Blusource, Project Hope, and Brothers Brother, demonstrates the value Camber places on giving back to the community. Through these organizations, Camber’s products have reached over 40 countries around the world, helping provide various prescriptions drugs from Antihypertensive to Antiretroviral medications. Camber is not only proud to provide resources that will assist the needs of many people, but views strategic donations as a responsibility to society. Camber is committed to providing donations in the future and is currently expanding their partnerships with charitable organizations.

Camber is a wholly owned subsidiary of Hetero Drugs based in Hyderabad, India. Hetero Drugs is a global pharmaceutical, research and development company with emphasis on API production and the manufacture of finished dosage forms and currently markets over 200 products and has a robust pipeline. Camber is in the early stages of adding an additional 300,000 sq. ft. of warehouse and distribution space near its current facility in Piscataway NJ. Camber’s associate company and manufacturing partner, Invagen Pharmaceuticals, Inc. located in Hauppauge, NY has recently added a 250,000 sq. ft. manufacturing facility, greatly increasing its capacity and bringing its total space to 375,000 sq. ft. Invagen focuses on wide range of therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and antidepressants. This combination of proficiencies gives Camber the unique ability to control every aspect of the manufacturing process, from API to finished dosage. With an impressive list of additional products scheduled for 2013, Camber is poised to become one of the largest generic pharmaceutical suppliers in the US.

For more information, visit camberpharma.com.